Symbiotic-GI-03: A randomized, double-blind, phase 3 study of first-line PF-08634404, a PD-1/VEGF bispecific antibody, in combination with mFOLFOX6 in patients with metastatic colorectal cancer (mCRC).
Cathy Eng, E Elez, Julien Taieb, Rui-Hua Xu et autres
0 citationsJournal of Clinical Oncology